CLOMAZOL

This brand name is authorized in Brazil, Ecuador, New Zealand

Active ingredients

The drug CLOMAZOL contains one active pharmaceutical ingredient (API):

1 Clotrimazole UNII G07GZ97H65 - CLOTRIMAZOLE

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc. Read about Clotrimazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CLOMAZOL Vaginal cream	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D01AC01	Clotrimazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 506302201166417
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 04465-MAN-10-06, 7.167-2-03-04, 7.183-2-04-04, 7.283-2-09-03
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11107, 11108, 13162